戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (left1)

通し番号をクリックするとPubMedの該当ページを表示します
1                         When combined with a serum LDH > 1500 IU/L, this is the most powerful poor pr
2 hroblasts in the spleen and bone marrow, and serum LDH level, consistent with ineffective erythropoie
3                                     Baseline serum LDH level was moderately accurate for predicting p
4   A significant interaction between baseline serum LDH and treatment was observed; oblimersen signifi
5 at 18 months (AUC = 0.813) than did baseline serum LDH levels alone for prediction of progression-fre
6 val in patients without an elevated baseline serum LDH.
7    In multivariate analysis, a high baseline serum LDH level was associated with decreased progressio
8                  The combination of baseline serum LDH levels and evaluation with MASS criteria at th
9                    A combination of baseline serum LDH levels and evaluation with MASS criteria at th
10 ncreased survival in patients whose baseline serum LDH was not elevated (median overall survival, 11.
11 overall or event-free survival, whereas both serum LDH and stage influenced both overall and event-fr
12                                     Elevated serum LDH or higher modified stage were associated with
13  2.22; 95% CI, 1.48-3.33; P < .001; elevated serum LDH: hazard ratio, 1.73; 95% CI, 1.16-2.58; P = .0
14                                  An elevated serum LDH concentration or a chest radiograph with granu
15 DH >two-thirds the upper limit of normal for serum LDH) were absent (LR, 0.04; 95% CI, 0.02-0.11).
16                                         High serum LDH levels are associated with poor prognosis in p
17  PFS in patients (n = 158 per arm) with high serum LDH, a potential marker of hypoxia, PFS was longer
18     FP15 reduced the DOX-induced increase in serum LDH and creatine kinase activities.
19 ion of baseline clinical variables including serum LDH and imaging findings with progression-free and
20  high-risk patients with pre-lymphodepletion serum LDH levels above normal, a favorable cytokine prof
21                         We hypothesized that serum LDH may represent a convenient biomarker of intrav
22 rotein >0.5, a ratio of pleural fluid LDH to serum LDH >0.6, or pleural fluid LDH >two-thirds the upp
23                            We tested whether serum LDH is prognostic and has predictive value in pati